<?xml version="1.0" encoding="UTF-8"?>
<p>Yamagata viruses circulating in 2017–2019 formed a monophyletic lineage (clade 3A in 
 <xref ref-type="fig" rid="fig01">Fig. 1</xref> and 
 <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1916585116/-/DCSupplemental" xlink:show="new" xmlns:xlink="http://www.w3.org/1999/xlink">
  <italic>SI Appendix</italic>, Fig. S15
 </ext-link>) in all segments. This clade is characterized by mutations in the NA at positions I171M and N342K and mutations in the PB1 (S591A) and PA (V326M) proteins (
 <xref ref-type="fig" rid="fig02">Fig. 2
  <italic>B</italic>
 </xref> and 
 <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1916585116/-/DCSupplemental" xlink:show="new" xmlns:xlink="http://www.w3.org/1999/xlink">
  <italic>SI Appendix</italic>, Figs. S15–S23
 </ext-link>), while no trunk amino acid substitutions were observed in the HA, PB2, nucleoprotein (NP), matrix protein (MP), and NS. More recently, a subgroup of clade 3A viruses have acquired 2 additional HA mutations at D229N and D232N, with the latter a potential N-glycosylation site. The mean TMRCAs of NA, PB1, and PA genes of Yamagata clade 3A defining mutations were estimated around May–June 2016 (mean TMRCA 2016.44 [95% HPD, 2016.22–2016.64], 2016.46 [2016.24–2016.67], and 2016.33 [2016.15–2016.63], respectively) (
 <xref rid="t02" ref-type="table">Table 2</xref> and 
 <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/lookup/suppl/doi:10.1073/pnas.1916585116/-/DCSupplemental" xlink:show="new" xmlns:xlink="http://www.w3.org/1999/xlink">
  <italic>SI Appendix</italic>, Figs. S15–S23
 </ext-link>), suggesting these mutations may have contributed to the severe epidemics observed in 2018 (
 <xref rid="r16" ref-type="bibr">16</xref>
 <xref rid="r17" ref-type="bibr"/>
 <xref rid="r18" ref-type="bibr"/>–
 <xref rid="r19" ref-type="bibr">19</xref>).
</p>
